MAPS remains “optimistic about treatment coverage, but not naive to the challenges”. MDMA therapy will need one of a kind protection beneath insurance, medicare, and medicaid. Far more information on coverage will come as we in close proximity to FDA approval. When will other nations around the world authorize MDMA and on what terms?Skip to pri